Zhejiang Starry Pharmaceutical Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 855.102 million compared to CNY 722.062 million a year ago. Operating income was CNY 201.621 million compared to CNY 183.894 million a year ago. Net income was CNY 155.647 million compared to CNY 139.685 million a year ago. Basic earnings per share from continuing operations was CNY 0.64 compared to CNY 0.59 a year ago.